Carmed Pharmaceuticals Highlights Second Peer-Reviewed Study of Its Formulations

Carmed Pharmaceuticals, a research-driven company specializing in standardized carvacrol-based formulations, is highlighting the publication of a new peer-reviewed scientific study involving two of its flagship formulations, Vacrol® and S-Mix®.

The research, recently published in the journal Antioxidants, represents the second peer-reviewed publication in 2026 involving Carmed formulations, further reflecting the company’s long-term commitment to scientific investigation, formulation development, and academic collaboration.

The study evaluated Vacrol® and S-Mix® in a series of laboratory and preclinical experimental models, examining formulation characteristics, biological activity, and antimicrobial properties. Researchers concluded that the formulations demonstrated distinct biological profiles and warranted further mechanistic and translational investigation.

Building a Research-Driven Foundation

Unlike many wellness companies that focus primarily on product marketing, Carmed Pharmaceuticals has invested heavily in scientific collaboration and research surrounding its proprietary formulations.

The newly published paper follows a January 2026 peer-reviewed study published in Plants that also evaluated Carmed formulations in experimental models. Together, the publications contribute to a growing body of scientific literature examining standardized carvacrol-based formulations and their biological properties.

“Scientific inquiry has always been central to our philosophy,” said Mustafa Can, Founder of Carmed Pharmaceuticals. “We believe meaningful innovation requires ongoing research, independent evaluation, and a willingness to explore important scientific questions through rigorous study.”

The company emphasizes that the published research reflects scientific investigation into formulation science and biological mechanisms and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

Supporting Long-Term Scientific Exploration

Carmed’s development approach focuses on standardized botanical formulations designed around reproducibility, analytical validation, and quality control.

The company collaborates with researchers, laboratories, healthcare institutions, and scientific advisors as part of its broader research ecosystem. These collaborations support ongoing investigation into botanical bioactives, formulation design, and potential mechanisms of action.

Expanding Availability in the United States

The publication comes as Carmed continues its expansion into the United States market.

Several Carmed formulations, coming soon to Amazon, are now available to U.S. consumers through OneLavi.com, including:

•  Vacrol® Kids Spray – A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.

• S-Mix® – A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule – A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule – A multi-component botanical formulation designed to support immune function and respiratory wellness.

According to the company, expanding retail availability alongside continued scientific publication reflects Carmed’s broader strategy of combining research, quality-focused formulation development, and long-term brand building as it establishes its presence in the U.S. market.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai Press Release Newswire – News Marketing Platform. The reference URL for this press release is located here Carmed Pharmaceuticals Highlights Second Peer-Reviewed Study of Its Formulations.

The post Carmed Pharmaceuticals Highlights Second Peer-Reviewed Study of Its Formulations appeared first on citybuzz.